Chemours Operating Cash Flow Growth & History (CC)
Chemours's operating cash flow was $264.0M for fiscal 2025.
View full Chemours company overviewChemours annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $264.0M | $897.0M | — |
| 2024 | 2024-12-31 | −$633.0M | −$1.19B | — |
| 2023 | 2023-12-31 | $556.0M | −$199.0M | −26.36% |
| 2022 | 2022-12-31 | $755.0M | −$59.0M | −7.25% |
| 2021 | 2021-12-31 | $814.0M | $7.0M | +0.87% |
| 2020 | 2020-12-31 | $807.0M | $157.0M | +24.15% |
| 2019 | 2019-12-31 | $650.0M | −$490.0M | −42.98% |
| 2018 | 2018-12-31 | $1.14B | $500.0M | +78.13% |
| 2017 | 2017-12-31 | $640.0M | $46.0M | +7.74% |
| 2016 | 2016-12-31 | $594.0M | $412.0M | +226.37% |
| 2015 | 2015-12-31 | $182.0M | −$323.0M | −63.96% |
| 2014 | 2014-12-31 | $505.0M | −$293.0M | −36.72% |
| 2013 | 2013-12-31 | $798.0M | — | — |
Chemours quarterly operating cash flow
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $158.0M | $65.0M | +69.89% |
| Q1 2026 | 2026-03-31 | −$44.0M | $68.0M | — |
| Q4 2025 | 2025-12-31 | $137.0M | −$1.0M | −0.72% |
| Q3 2025 | 2025-09-30 | $146.0M | $7.0M | +5.04% |
| Q2 2025 | 2025-06-30 | $93.0M | $713.0M | — |
| Q1 2025 | 2025-03-31 | −$112.0M | $178.0M | — |
| Q4 2024 | 2024-12-31 | $138.0M | −$344.0M | −71.37% |
| Q3 2024 | 2024-09-30 | $139.0M | $8.0M | +6.11% |
| Q2 2024 | 2024-06-30 | −$620.0M | −$687.0M | — |
| Q1 2024 | 2024-03-31 | −$290.0M | −$166.0M | — |
| Q4 2023 | 2023-12-31 | $482.0M | $321.0M | +199.38% |
| Q3 2023 | 2023-09-30 | $131.0M | −$170.0M | −56.48% |
| Q2 2023 | 2023-06-30 | $67.0M | −$224.0M | −76.98% |
| Q1 2023 | 2023-03-31 | −$124.0M | −$126.0M | — |
| Q4 2022 | 2022-12-31 | $161.0M | −$47.0M | −22.60% |
| Q3 2022 | 2022-09-30 | $301.0M | −$10.0M | −3.22% |
| Q2 2022 | 2022-06-30 | $291.0M | $35.0M | +13.67% |
| Q1 2022 | 2022-03-31 | $2.0M | −$37.0M | −94.87% |
| Q4 2021 | 2021-12-31 | $208.0M | −$145.0M | −41.08% |
| Q3 2021 | 2021-09-30 | $311.0M | $12.0M | +4.01% |
| Q2 2021 | 2021-06-30 | $256.0M | $145.0M | +130.63% |
| Q1 2021 | 2021-03-31 | $39.0M | −$5.0M | −11.36% |
| Q4 2020 | 2020-12-31 | $353.0M | −$47.0M | −11.75% |
| Q3 2020 | 2020-09-30 | $299.0M | $11.0M | +3.82% |
| Q2 2020 | 2020-06-30 | $111.0M | $105.0M | +1750.00% |
| Q1 2020 | 2020-03-31 | $44.0M | $88.0M | — |
| Q4 2019 | 2019-12-31 | $400.0M | $141.0M | +54.44% |
| Q3 2019 | 2019-09-30 | $288.0M | −$54.0M | −15.79% |
| Q2 2019 | 2019-06-30 | $6.0M | −$337.0M | −98.25% |
| Q1 2019 | 2019-03-31 | −$44.0M | −$240.0M | — |
| Q4 2018 | 2018-12-31 | $259.0M | −$44.0M | −14.52% |
| Q3 2018 | 2018-09-30 | $342.0M | $230.0M | +205.36% |
| Q2 2018 | 2018-06-30 | $343.0M | $159.0M | +86.41% |
| Q1 2018 | 2018-03-31 | $196.0M | $155.0M | +378.05% |
| Q4 2017 | 2017-12-31 | $303.0M | $33.0M | +12.22% |
| Q3 2017 | 2017-09-30 | $112.0M | −$86.0M | −43.43% |
| Q2 2017 | 2017-06-30 | $184.0M | $94.0M | +104.44% |
| Q1 2017 | 2017-03-31 | $41.0M | $5.0M | +13.89% |
| Q4 2016 | 2016-12-31 | $270.0M | −$32.0M | −10.60% |
| Q3 2016 | 2016-09-30 | $198.0M | $85.0M | +75.22% |
| Q2 2016 | 2016-06-30 | $90.0M | $85.0M | +1700.00% |
| Q1 2016 | 2016-03-31 | $36.0M | $274.0M | — |
| Q4 2015 | 2015-12-31 | $302.0M | — | — |
| Q3 2015 | 2015-09-30 | $113.0M | −$129.0M | −53.31% |
| Q2 2015 | 2015-06-30 | $5.0M | — | — |
| Q1 2015 | 2015-03-31 | −$238.0M | — | — |
| Q3 2014 | 2014-09-30 | $242.0M | — | — |
Chemours operating cash flow trends
Over the last five fiscal years, Chemours's operating cash flow decreased from $807.0M to $264.0M, a change of −$543.0M. The latest reported quarter, Q2 2026, shows $158.0M.
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...